In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results